Skip to main content
Download PDF

Treatment of Naturally Notoedres cati-infested Cats with a Combination of Imidacloprid 10 % / Moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer)

Parasitology Research volume 112, pages 57–66 (2013)Cite this article

Author information

Affiliations

  1. KLIFOVET AG, 80689, München, Germany

    Klaus Hellmann & Dejan Cvejic

  2. Bayer Animal Health GmbH, 51368, Leverkusen, Germany

    Gabriele Petry

  3. Kapriol Bt., 8330, Sümeg, Hungary

    Balazs Capari

  4. Institute for Parasitology and Tropical Veterinary Medicine, Faculty of Veterinary Medicine, Free University Berlin, 14163, Berlin, Germany

    Friederike Krämer

Authors
  1. Klaus Hellmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriele Petry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Balazs Capari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dejan Cvejic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Friederike Krämer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriele Petry.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Hellmann, K., Petry, G., Capari, B. et al. Treatment of Naturally Notoedres cati-infested Cats with a Combination of Imidacloprid 10 % / Moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer). Parasitol Res 112, 57–66 (2013). https://doi.org/10.1007/s00436-013-3281-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-013-3281-y

Keywords

  • Imidacloprid
  • Ivermectin
  • Negative Control Group
  • Scabies
  • Moxidectin